147 related articles for article (PubMed ID: 38382346)
1. PS-MPs promotes the progression of inflammation and fibrosis in diabetic nephropathy through NLRP3/Caspase-1 and TGF-β1/Smad2/3 signaling pathways.
Feng L; Chen C; Xiong X; Wang X; Li X; Kuang Q; Wei X; Gao L; Niu X; Li Q; Yang J; Li L; Luo P
Ecotoxicol Environ Saf; 2024 Mar; 273():116102. PubMed ID: 38382346
[TBL] [Abstract][Full Text] [Related]
2. Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation.
Zhou Z; Ying C; Zhou X; Shi Y; Xu J; Zhu Y; Wang M; Li Y; Li X; Xiang J
Exp Gerontol; 2022 Oct; 168():111934. PubMed ID: 36007721
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
4. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
[TBL] [Abstract][Full Text] [Related]
5. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
7. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.
Wang W; Wang X; Chun J; Vilaysane A; Clark S; French G; Bracey NA; Trpkov K; Bonni S; Duff HJ; Beck PL; Muruve DA
J Immunol; 2013 Feb; 190(3):1239-49. PubMed ID: 23264657
[TBL] [Abstract][Full Text] [Related]
8. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
9. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
[TBL] [Abstract][Full Text] [Related]
10. Ambient particulate matter exposure plus a high-fat diet exacerbate renal injury by activating the NLRP3 inflammasome and TGF-β1/Smad2 signaling pathway in mice.
Jiang J; Ding S; Zhang G; Dong Y
Ecotoxicol Environ Saf; 2022 Jun; 238():113571. PubMed ID: 35512472
[TBL] [Abstract][Full Text] [Related]
11. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice.
Ram C; Gairola S; Syed AM; Kulhari U; Kundu S; Mugale MN; Murty US; Sahu BD
Life Sci; 2022 Jun; 298():120527. PubMed ID: 35378138
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
Liu Y; Xu Z; Ma F; Jia Y; Wang G
Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in
Zhang Q; Liu X; Sullivan MA; Shi C; Deng B
Oxid Med Cell Longev; 2021; 2021():7958021. PubMed ID: 34504642
[TBL] [Abstract][Full Text] [Related]
14. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
15. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
[TBL] [Abstract][Full Text] [Related]
16. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice.
Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B
J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
18. Polystyrene microplastics lead to pyroptosis and apoptosis of ovarian granulosa cells via NLRP3/Caspase-1 signaling pathway in rats.
Hou J; Lei Z; Cui L; Hou Y; Yang L; An R; Wang Q; Li S; Zhang H; Zhang L
Ecotoxicol Environ Saf; 2021 Apr; 212():112012. PubMed ID: 33550074
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-β signaling pathway on interstitial cystitis/bladder pain syndrome.
Shih HJ; Chang CY; Lai CH; Huang CJ
Biomed Pharmacother; 2021 Jun; 138():111522. PubMed ID: 34311526
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
